BioCentury
ARTICLE | Company News

Pfizer to acquire sterile injectable company InnoPharma

July 17, 2014 12:55 AM UTC

Pfizer Inc. (NYSE:PFE) will acquire InnoPharma Inc. (Piscataway, N.J.) for $225 million in cash up front. InnoPharma is also eligible for up to $135 million in milestones. InnoPharma develops sterile injectable formulations of generic drugs, and its portfolio includes 10 products approved in the U.S. and 19 products under FDA review.

Pfizer said the acquisition will bolster its sterile injectables portfolio to 73 products. The company's injectables portfolio is part of its Global Established Pharma business. ...